NINR Acting Director and Scientific Director Ann K. Cashion, PhD, RN, FAAN, will retire from federal service, effective September 30. Dr. Cashion has served as Acting Director for the past year, and as NINR Scientific Director since 2013.
Dr. Cashion arrived at NINR in 2011 as a Senior Advisor to then-NINR Director Patricia A. Grady, PhD, RN, FAAN. She also served as the Acting NINR Scientific Director before being named permanent Scientific Director. In this role, she established a thriving intramural research program focused on advancing symptom science, a program that now includes the NINR-led, trans-NIH Symptom Science Center. Additionally, with then-NINR Director Patricia A. Grady, PhD, RN, FAAN, Dr. Cashion developed the NIH Symptom Science Model to guide symptoms research in the intramural program.
Before joining NIH, Dr. Cashion was professor and chair of the Department of Acute and Chronic Care in the College of Nursing, University of Tennessee Health Science Center (UTHSC). She joined the faculty in 2000, shortly after earning her doctorate at UTHSC. During her tenure there, Dr. Cashion researched social, environmental, and genetic markers to predict patient outcomes and guide therapies in solid organ transplant recipients. She also shared her expertise, mentoring numerous doctoral students on how to incorporate genomics into their programs of research.
NIH soon will be re-opening the search for a new permanent Director of NINR. Following Dr. Cashion’s departure, NIH Principal Deputy Director Lawrence A. Tabak, DDS, PhD, will serve as the Acting Director of NINR. In addition, NIH Associate Deputy Director Tara A. Schwetz, PhD, will serve as NINR’s Acting Deputy Director, effective August 26, managing the day-to-day operations of the Institute. Jessica M. Gill, PhD, RN, FAAN, currently NINR’s Deputy Scientific Director, will serve as the Acting Scientific Director.
Read a message from Dr. Cashion on her announcement.